glp-1 dpp 4 DPP4 Inhibitors vs Agonists | June 2021 | Clinical Corner GLP-1-RA and DPP-4 inhibitors in

This article reviews what is currently known about the relationship between GLP-1 therapies and hypertension, while offering practical guidance on how to apply these findings in real-world care

Neurological assessments were performed using ARAT, Ashworth, and DASH scales

GLP (glucagon-like peptide) receptor agonists are a class of medications that have been approved by the FDA for the treatment of type 2 diabetes and for weight loss

Many people with sulfa allergies and sensitivities may be able to safely take the following medications but should do so with caution: some diabetes medications, including glyburide (Glynase, Diabeta) and glimepiride (Amaryl) migraine medication sumatriptan (Imitrex, Sumavel, and Dosepro) some diuretics, including hydrochlorothiazide (Microzide) and furosemide (Lasix) The ability to take these medications can vary from person to person

Diabetes Obes Metab (2019) 21:4348